TipRanks
Global Cord Blood (CORBF)
OTHER OTC:CORBF
US Market

Compare Global Cord Blood (CORBF) vs. Competitors

179 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Global Cord Blood
$0.95
$127.35M
1.55
-5.84%
―
Myriad Genetics
$3.19
$404.60M
-3.62
-40.39%
0 Buy
4 Hold
3 Sell
Moderate Sell
Natera
$336.71
$59.75B
-302.76
156.76%
20 Buy
1 Hold
0 Sell
Strong Buy
Prenetics Group
$23.25
$391.56M
-5.54
73.91%
5 Buy
0 Hold
0 Sell
Strong Buy
Sera Prognostics
$2.09
$79.29M
-3.09
-31.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
BillionToOne, Inc. Class A
$99.39
$5.58B
174.63
-2.29%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CORBF
Global Cord Blood
0.95
-0.05
-4.90%
MYGN
Myriad Genetics
4.31
-3.42
-44.24%
NTRA
Natera
413.31
251.70
155.75%
PRE
Prenetics Group
23.13
8.53
58.42%
SERA
Sera Prognostics
2.09
-0.86
-29.15%
BLLN
BillionToOne, Inc. Class A
106.44
-2.50
-2.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts